Horizon Pharma plc Updates Presentation Time at the JMP Securities 2015 Life Sciences Conference

DUBLIN, IRELAND--(Marketwired - Jun 16, 2015) -  Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced it will present at the JMP Securities 2015 Life Sciences on Tuesday, June 23, 2015 at 11:30 a.m. ET.

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days.

About Horizon Pharma plc

Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

Investors:

John B. Thomas
Executive Vice President, Corporate Strategy and Investor Relations
Email Contact

U.S. Media Contact:

Geoff Curtis
Group Vice President, Corporate Communications
Email Contact